Alpha Fetoprotein: What Patients Need to Know

Alpha fetoprotein is a protein measured in blood that can help doctors assess pregnancy-related questions and support the evaluation or monitoring of certain liver and germ cell conditions. By itself, an alpha fetoprotein result is not a diagnosis; it is one piece of information interpreted alongside symptoms, imaging, and other tests.

Overview: what alpha fetoprotein means

Alpha fetoprotein is a protein made mainly by a developing fetus and, in adults, sometimes by certain liver cells or tumors. Doctors most often measure it with a simple blood test called an AFP test. The result can help answer different clinical questions depending on why the test was ordered.

In pregnancy, AFP may be part of prenatal screening. Outside pregnancy, alpha fetoprotein can be used as a tumor marker, especially when doctors are evaluating some liver cancers or germ cell tumors, or monitoring a person after treatment. It may also rise in some noncancerous liver conditions, such as hepatitis or cirrhosis.

What matters most for patients is that AFP is a clue, not a standalone answer. A normal result does not rule out every problem, and an abnormal result does not automatically mean cancer or a pregnancy complication. Doctors interpret AFP together with medical history, physical examination, imaging, and often repeat blood tests.

Why doctors order an AFP blood test

The reason for testing shapes the meaning of the result. In pregnancy, AFP can be part of screening for certain fetal conditions, usually along with ultrasound and other blood markers. Timing is important because AFP values change during pregnancy, and an incorrect estimate of gestational age can make a result appear abnormal when it is not.

In adults who are not pregnant, alpha fetoprotein may be used in several situations. A clinician may order it when investigating a liver mass, monitoring people with known liver disease, or following treatment for a cancer that can produce AFP. It is often used alongside imaging tests rather than as a replacement for them.

Common reasons an AFP test may be ordered include:

• Screening as part of prenatal care
• Evaluating a suspected liver tumor
• Monitoring conditions such as chronic hepatitis or cirrhosis
• Following response to treatment for some germ cell tumors
• Checking for recurrence after cancer treatment

Because one test can serve different purposes, patients often benefit from asking a simple question at the time of testing: “What is this AFP test looking for in my case?” That context can make the result much easier to understand.

What high or low AFP levels can suggest

An elevated alpha fetoprotein level can have several explanations. In adults, it may be seen in some liver cancers, especially liver cancer, and in certain germ cell tumors involving the testes or ovaries. However, AFP can also rise with noncancerous liver injury, including active hepatitis, cirrhosis, or liver regeneration after damage.

In pregnancy, higher-than-expected AFP levels may be linked with more than one fetus, differences in pregnancy dating, or certain fetal conditions. Lower-than-expected levels can also be meaningful in prenatal screening, but they are never interpreted in isolation. Ultrasound, repeat testing, and sometimes other screening or diagnostic tests are used to clarify the picture.

A normal AFP level can be reassuring, but it does not exclude every disease. Some liver cancers do not produce much AFP, and many noncancerous problems can occur with a normal value. Likewise, a mildly abnormal result may simply reflect inflammation or a temporary change rather than a serious diagnosis.

For this reason, trends over time can be more useful than a single number. A falling AFP after treatment may suggest a response, while a rising level can prompt closer follow-up. Even then, doctors usually confirm concerns with imaging such as ultrasound, CT, or MRI.

Causes and risk factors linked to abnormal AFP

Abnormal AFP levels are best understood by looking at the underlying condition rather than the blood test itself. In adults, the most important associations are chronic liver disease, liver tumors, and certain germ cell tumors. People with long-term hepatitis B or hepatitis C, cirrhosis, heavy alcohol-related liver damage, or fatty liver disease with advanced scarring may be more likely to need AFP testing as part of a broader evaluation.

Some cancers can release AFP into the bloodstream. These include hepatocellular carcinoma, the most common primary liver cancer, and some testicular or ovarian germ cell tumors. If doctors are evaluating one of these conditions, AFP may be combined with other tumor markers and scans to improve accuracy. Depending on the case, this may be paired with medical oncology care or interventional radiology procedures as part of diagnosis or treatment planning.

Benign conditions can also affect AFP. Liver inflammation from viral hepatitis, medication-related injury, or other causes may temporarily increase the level. During pregnancy, normal physiologic changes are an important source of AFP, which is why pregnancy-related AFP ranges are different from adult nonpregnant ranges.

Risk factors that may prompt AFP testing include:

• Known chronic liver disease or cirrhosis
• A liver lesion seen on imaging
• Symptoms such as jaundice, unexplained weight loss, abdominal swelling, or persistent upper abdominal discomfort
• A history of germ cell tumor
• Pregnancy screening recommended by an obstetric clinician

How AFP results are interpreted and what tests may follow

Laboratories may use different reference ranges, so the report should always be reviewed with the ordering clinician. The number itself is less important than the clinical setting, how far it is from the expected range, and whether it is changing over time. In pregnancy, the stage of pregnancy is essential for correct interpretation.

If AFP is abnormal, doctors may recommend repeat blood testing to confirm the result and look for a trend. Additional tests can include liver function tests, hepatitis screening, and other tumor markers. Imaging is often a key next step, especially if a liver or pelvic mass is suspected.

Depending on the concern, follow-up evaluation may involve abdominal ultrasound, CT, or MRI. If a suspicious lesion is found, referral to specialists may be needed. In liver-related cases, patients may also be assessed for liver transplant eligibility when advanced liver disease is present, although many people do not need this level of treatment.

In prenatal care, an abnormal AFP result usually leads to careful review of pregnancy dating, targeted ultrasound, and discussion of whether further testing is appropriate. The goal is to clarify the finding as accurately and safely as possible, not to jump to conclusions based on a screening result alone.

Treatment and follow-up depend on the cause

There is no treatment aimed at AFP itself. Care focuses on the condition that caused the abnormal result. If AFP is elevated because of liver inflammation, the next step may be treatment of the liver disease and monitoring over time. If the result is related to pregnancy screening, management is guided by obstetric findings and additional testing.

When AFP is linked to cancer, treatment depends on the tumor type, stage, the person’s overall health, and whether the disease can be removed or controlled. Options may include surgery, systemic therapy, ablation, embolization, radiation-based techniques, or active surveillance in selected cases. Patients being assessed for testicular cancer or liver tumors often have AFP measured before, during, and after treatment to track response.

Follow-up is often just as important as the first result. A declining AFP may suggest that treatment is working, while a stable or rising value may mean the care plan needs reassessment. Still, clinicians confirm progress with examination and imaging, not AFP alone.

For international patients who need coordinated evaluation, Acibadem International’s multidisciplinary specialists in JCI-accredited hospitals diagnose and treat liver and tumor-related conditions using laboratory testing, imaging, and individualized treatment planning.

Prevention and self-care

Patients cannot directly control their AFP level, but they can reduce the chance of some underlying causes, especially liver disease. Protecting liver health is one of the most practical steps. This includes limiting alcohol, maintaining a healthy weight, managing diabetes if present, and following medical advice for fatty liver disease.

Vaccination and treatment can also matter. Hepatitis B vaccination helps prevent a major cause of chronic liver disease and liver cancer. People with hepatitis B or hepatitis C should stay in regular follow-up, because timely treatment and surveillance may reduce complications.

Helpful self-care measures include:

• Keeping scheduled blood tests and imaging appointments
• Taking prescribed medications as directed
• Avoiding unapproved supplements that may affect the liver
• Reporting new symptoms such as jaundice, abdominal swelling, or unexplained weight loss
• Discussing family history and personal risk factors with a doctor

During pregnancy, the best approach is to attend routine prenatal visits and ask how screening results fit into the overall picture. Most abnormal screening tests still require confirmation, and many do not lead to a serious diagnosis.

When to seek medical care

Patients should contact a doctor if they have an abnormal AFP result and are unsure what it means, especially if the test was ordered because of a known liver problem, a mass seen on imaging, or prior cancer treatment. Questions are also appropriate when a result seems unexpected or when repeat testing has been recommended.

More prompt medical review is important if symptoms suggest liver disease or a significant underlying condition. These symptoms can include yellowing of the skin or eyes, increasing abdominal swelling, vomiting blood, severe fatigue, unexplained weight loss, a new testicular lump, or persistent abdominal pain.

In pregnancy, patients should speak with their obstetric clinician if AFP screening is reported as abnormal. Most cases need clarification rather than urgent intervention, but timely follow-up helps ensure that appropriate ultrasound or additional testing is arranged.

Emergency care is needed for severe bleeding, confusion, fainting, or sudden severe abdominal symptoms. For nonemergency concerns, a qualified clinician can explain whether AFP should be repeated, monitored, or interpreted alongside further investigations.

Frequently asked questions

What is alpha fetoprotein used for?

Alpha fetoprotein is used as a blood marker in two main settings: pregnancy care and the evaluation or monitoring of certain tumors and liver diseases. It can support diagnosis and follow-up, but it does not provide a diagnosis by itself.

Does a high AFP level mean cancer?

No. A high AFP level can be seen in some cancers, especially certain liver and germ cell tumors, but it can also rise in noncancerous liver conditions such as hepatitis or cirrhosis. Doctors usually need imaging and other tests to understand the cause.

Can AFP be normal even if a person has liver cancer?

Yes. Some liver cancers do not produce much AFP, so a normal result does not completely rule out disease. That is why AFP is often combined with ultrasound, CT, MRI, and other clinical information.

Why would AFP be tested during pregnancy?

During pregnancy, AFP may be included in prenatal screening to help assess the chance of certain fetal conditions. The result depends on the stage of pregnancy, so correct dating and follow-up ultrasound are important.

How is an AFP test done?

An AFP test is usually done with a standard blood sample taken from a vein. Most people do not need any special preparation, although the ordering clinician may give specific instructions based on the reason for testing.

What happens after an abnormal AFP result?

The next step depends on why the test was ordered. A doctor may repeat the blood test, order imaging, request other laboratory tests, or refer the patient to a specialist such as a hepatologist, oncologist, or obstetric clinician.

References

• World Health Organization
• American Cancer Society
• National Cancer Institute
• American College of Obstetricians and Gynecologists
• Centers for Disease Control and Prevention

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.